Deals
Galderma Agrees to Buy Q-Med to Gain Wrinkle Smoother Restylane
This article is for subscribers only.
Galderma SA, the Swiss maker of Cetaphil skin creams, agreed to buy Sweden’s Q-Med AB for as much as 7.45 billion kronor ($1.08 billion) to add products that smooth wrinkles and enhance breasts.
Q-Med shareholders other than founder and Chairman Bengt Aagerup will receive 75 kronor a share in cash, the Swedish company said in a statement today. That’s 13 percent more than the stock’s Dec. 10 closing price of 66.25 kronor. The stock rose as much as 15 percent, the most in 19 months, after the announcement. Galderma, founded in 1981, is owned by L’Oreal SA and Nestle SA.